XIFIN Blog Lâle White

Follow Us
lale.white's picture

Termination of the BlueCard Program Runs Afoul of State and Federal Regulations

Submitted by lale.white on Tue, 2012-06-19 11:10
Tue, 2012-06-19 11:08
Blue plans attempting to reconcile the non-standard claims filing rules imposed by BCBS associated with the termination of the BlueCard program are running afoul of state and federal regulations; from non-adherence to HIPAA electronic standards to ignoring state assignment laws.
lale.white's picture

Who if anyone benefits from the dismantling of the BlueCard® program?

Submitted by lale.white on Tue, 2012-06-12 10:20
Tue, 2012-06-12 10:18
The new system turns a straightforward process into an unnecessarily complicated and expensive one. Is the BCBS Association, forcing the Blues to enforce their exclusivity arrangements that disadvantage regional labs and prohibit them from competing in the market place?
lale.white's picture

XIFIN and CCLA Urge Labs: Test and Go Live with 5010 Now to Avoid Payment Disruptions

Submitted by lale.white on Tue, 2012-05-01 10:27
Tue, 2012-05-01 10:25
lale.white's picture

Produce Optimal Results or Perish: Technology and Information Force Economic Discipline on Healthcare Providers

Submitted by lale.white on Mon, 2012-04-16 10:40
Mon, 2012-04-16 10:39
Computing power was ultimately the linchpin to unleashing the mapping of the human genome and thus a whole new world of diagnostics and personalized medicine.. HIT and web services from content providers offers the infrastructure to facilitate analysis of results and thus the provision of targeted decision support fostering a paradigm change that shifts the tides of diagnostics to personalized medicine with decision support, optimal outcomes and ultimately value based pricing.
lale.white's picture

11 Real-World 5010 Issues and How to Resolve Them

Submitted by lale.white on Mon, 2012-01-16 09:39
Mon, 2012-01-16 10:37
XIFIN experts, Lâle White and Matt Warner were asked to present some key strategies for submitting and getting paid on clean 5010 claims as well as some real-life examples of 5010 challenges and their solutions. As a service to the lab industry and providers everywhere, we are posting a series of real-world use cases for different 5010 challenges and how to resolve them.
lale.white's picture

2012 Outlook: Overreactive Legislature and Economic Uncertainty Bring Dark Cloud Over Advancing Lab Industry

Submitted by lale.white on Thu, 2011-12-22 09:37
Thu, 2011-12-22 10:35
Just as molecular diagnostics and genetic testing are poised to effectuate a technological paradigm change in healthcare delivery and outcomes, possibly the most significant impact to healthcare economics in our lifetime, an overreactive legislature is putting the brakes on.
lale.white's picture

4 Reasons Molecular Dx Labs May Not Benefit From New CED Program

Submitted by lale.white on Tue, 2011-11-29 09:47
Tue, 2011-11-29 10:46
Diagnostic services already face challenges in recouping R&D costs. Lower fee schedules, coverage for "investigational" services likely to stifle investment and development.
lale.white's picture

White Paper Explains 5 Key Trends Driving CEOs to Next Generation Revenue Cycle Management

Submitted by lale.white on Tue, 2011-10-18 11:13
Tue, 2011-10-18 11:11
The rapid and wide-ranging changes to healthcare are magnified in the diagnostic services segment because diagnostic services influence 70% of healthcare decisions. Diagnostic service providers who fail to rapidly and aggressively adapt to this ever-changing environment do so at their peril. Because the RCM system is the system of record and therefore the lifeblood of any diagnostic service organization, a dramatic rethinking of the role of RCM systems is necessary to ensure service providers continue to successfully compete in the health services market.

Interested In Learning More? Contact us to learn how XIFIN can help your business. Call us at (858) 436-2995 or click here to complete a brief information request form.